JHS Svendgaard Laboratories Limited (IN:JHS)
:JHS
Want to see IN:JHS full AI Analyst Report?
JHS Stock Chart & Stats
₹9.34
₹0.02(0.10%)
At close: 4:00 PM EST
₹9.34
₹0.02(0.10%)
Day’s Range― - ―
52-Week Range₹6.15 - ₹16.20
Previous CloseN/A
Volume57.31K
Average Volume (3M)16.78K
Market Cap
₹770.44M
Enterprise Value₹721.81M
Total Cash (Recent Filing)₹200.11M
Total Debt (Recent Filing)₹105.87M
Price to Earnings (P/E)27.3
Beta1.10
Next Earnings
Jun 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding85,603,966
10 Day Avg. Volume16,348
30 Day Avg. Volume16,781
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.57
Price to Sales (P/S)1.06
P/FCF Ratio-6.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetVery high equity ratio and negligible debt give durable financial flexibility. This lowers refinancing and interest-rate risk, supports capital spending or working-capital needs, and provides a stable runway for operational restructuring or capacity investments over the next several quarters.
Contract Manufacturing ModelA contract manufacturing/private-label business delivers recurring, volume-driven revenue with lower brand marketing spend. Long-term supply relationships and predictable order streams can enable stable utilization, scalable margins, and resilience to demand shifts if customer retention is maintained.
Improved Gross MarginAn improved gross margin suggests stronger cost control, better input sourcing, or favorable product mix. Sustaining higher gross profitability is a critical structural lever to move toward breakeven, offset fixed overhead, and rebuild operating margins if volume and SG&A are managed.
Bears Say
Multi-year Revenue DeclinePersistent top-line contraction reduces operating leverage and leaves production capacity underutilized. For a volume-driven contract manufacturer, declining revenue impairs fixed-cost absorption, weakens bargaining power with suppliers, and makes margin recovery and scale economics harder to achieve.
Sustained Losses / Negative MarginsMulti-year net losses erode retained earnings and limit internal funding for investment. Continued negative margins imply structural issues—pricing, mix, or overhead—that prevent free cash generation and make operational turnaround dependent on meaningful margin improvement or structural cost reductions.
Deteriorating Cash ConversionWorsening free cash flow and poor conversion of income into operating cash strain liquidity and increase reliance on external financing. Even with low debt, negative cash generation limits ability to invest in capacity, meet working-capital needs, or withstand prolonged revenue weakness without dilutive remedies.
JHS Svendgaard Laboratories Limited News
JHS FAQ
What was JHS Svendgaard Laboratories Limited’s price range in the past 12 months?
JHS Svendgaard Laboratories Limited lowest stock price was ₹6.15 and its highest was ₹16.20 in the past 12 months.
What is JHS Svendgaard Laboratories Limited’s market cap?
JHS Svendgaard Laboratories Limited’s market cap is ₹770.44M.
When is JHS Svendgaard Laboratories Limited’s upcoming earnings report date?
JHS Svendgaard Laboratories Limited’s upcoming earnings report date is Jun 02, 2026 which is in 34 days.
How were JHS Svendgaard Laboratories Limited’s earnings last quarter?
JHS Svendgaard Laboratories Limited released its earnings results on Feb 10, 2026. The company reported ₹0.092 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.092.
Is JHS Svendgaard Laboratories Limited overvalued?
According to Wall Street analysts JHS Svendgaard Laboratories Limited’s price is currently Overvalued.
Does JHS Svendgaard Laboratories Limited pay dividends?
JHS Svendgaard Laboratories Limited pays a Annually dividend of ₹0.75 which represents an annual dividend yield of N/A. See more information on JHS Svendgaard Laboratories Limited dividends here
What is JHS Svendgaard Laboratories Limited’s EPS estimate?
JHS Svendgaard Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JHS Svendgaard Laboratories Limited have?
JHS Svendgaard Laboratories Limited has 85,603,966 shares outstanding.
What happened to JHS Svendgaard Laboratories Limited’s price movement after its last earnings report?
JHS Svendgaard Laboratories Limited reported an EPS of ₹0.092 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.965%.
Which hedge fund is a major shareholder of JHS Svendgaard Laboratories Limited?
Currently, no hedge funds are holding shares in IN:JHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JHS Svendgaard Laboratories Limited
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture products under the Dr. Gold and Aquawhite brands. It also provides contract manufacturing services for oral care products of other brands; and operates retail stores at airports. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1996 and is based in New Delhi, India.
Technical Analysis
Colgate-Palmolive (India) Limited
―
Dabur India Limited
―
Emami Limited
―
Godrej Consumer Products Limited
―
Honasa Consumer Limited
―